Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2007

View Archived Issues

Recent patents describe new antidiabetic agents

Novel therapeutic options for obesity described in recent patent literature

Recent patents disclose novel antiinfective agents

Varenicline shows promise in preclinical models of alcohol dependence

CVBT-141F successfully completes preclinical stroke research

Pediatric phase II clinical trial of Intercell's JE vaccine begins in India

Opko Health initiates phase III trial of bevasiranib in wet AMD

Ghrelin receptor: Target To Watch for development of therapeutics for severe gastroparesis

Plethora secures funds for development of Invicorp for treatment of ED

Enrollment in Angiotech's CVC pivotal study completed

FDA approves initiation of phase III trials for Protalix's prGCD

Enrollment for CSL's phase III trial of subcutaneous immunoglobulin completed

H5N1 influenza antigen delivered to DelSite

Uluru and ImmuneRegen to codevelop wound care therapeutic

Update on Antisoma's phase II trial of ASA-404 for ovarian cancer

Positive results for Vernalis' phase IIa trial of V-3381 for neuropathic pain

YM reports secondary findings of phase IIb trial of AeroLEF for pain

FDA approves GeneSearch Breast Lymph Node Assay

Extina Foam approved for seborrheic dermatitis

First launch for Torisel

Ceftobiprole submissions accepted for review in U.S. and E.U.

Priority review for Abilify in treatment of major depressive disorder

VX-765 demonstrates antiseizure activity in animals

Studies reveal activity, pharmacokinetics of the antiepileptic eslicarbazepine

Studies profile lacosamide in epilepsy

Nerviano presents first Cdc7 kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...